Evidence map›Paper›PMID 36649223›Full record

ArticleJMIR formative research2023

mHealth App to Facilitate Remote Care for Patients With COVID-19: Rapid Development of the DrCovid+ App.

Jamaica Pei Ying Tan, Michelle W J Tan, Rachel Marie Towle, Joanne Sze Win Lee, Xiaofeng Lei, Yong Liu, Rick Siow Mong Goh, Franklin Tan Chee Ping, Teck Choon Tan, Daniel Shu Wei Ting and 2 more

Open access · goldAbstract read
In one paragraph

Article in JMIR formative research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Jamaica Pei Ying TanPopulation Health and Integrated Care Office, Singapore General Hospital, Singapore, Singapore.ORCID https://orcid.org/0000-0003-2373-4747
Michelle W J TanPopulation Health and Integrated Care Office, Singapore General Hospital, Singapore, Singapore.ORCID https://orcid.org/0000-0003-0766-2501
Rachel Marie TowlePopulation Health and Integrated Care Office, Singapore General Hospital, Singapore, Singapore.ORCID https://orcid.org/0000-0002-5266-7574
Joanne Sze Win LeePopulation Health and Integrated Care Office, Singapore General Hospital, Singapore, Singapore.ORCID https://orcid.org/0000-0001-9133-0379
Xiaofeng LeiInstitute of High Performance Computing, Agency for Science, Technology and Research, Singapore, Singapore.ORCID https://orcid.org/0000-0001-9290-9198
Yong LiuInstitute of High Performance Computing, Agency for Science, Technology and Research, Singapore, Singapore.ORCID https://orcid.org/0000-0002-1590-2029
Rick Siow Mong GohInstitute of High Performance Computing, Agency for Science, Technology and Research, Singapore, Singapore.ORCID https://orcid.org/0000-0001-9116-1595
Franklin Tan Chee PingOffice for Service Transformation, Singapore Health Services, Singapore, Singapore.ORCID https://orcid.org/0000-0002-8991-7645
Teck Choon TanOffice for Service Transformation, Singapore Health Services, Singapore, Singapore.ORCID https://orcid.org/0000-0003-4746-5668
Daniel Shu Wei TingDepartment of Ophthalmology, Singapore National Eye Centre, Singapore, Singapore.ORCID https://orcid.org/0000-0003-2264-7174
Chen Ee LeeInnovation and Transformation, Singapore Health Services, Singapore, Singapore.ORCID https://orcid.org/0000-0002-1237-6377
Lian Leng LowPopulation Health and Integrated Care Office, Singapore General Hospital, Singapore, Singapore.ORCID https://orcid.org/0000-0003-4228-2862
Singapore General Hospital · SGAgency for Science, Technology and Research · SGSingHealth · SGMinistry of Health · SGNational University of Singapore · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe 2019 novel COVID-19 has severely burdened the health care system through its rapid transmission. Mobile health (mHealth) is a viable solution to facilitate remote monitoring and continuity of care for patients with COVID-19 in a home environment. However, the conceptualization and development of mHealth apps are often time and labor-intensive and are laden with concerns relating to data security and privacy. Implementing mHealth apps is also a challenging feat as language-related barriers limit adoption, whereas its perceived lack of benefits affects sustained use. The rapid development of an mHealth app that is cost-effective, secure, and user-friendly will be a timely enabler.

objectiveThis project aimed to develop an mHealth app, DrCovid+, to facilitate remote monitoring and continuity of care for patients with COVID-19 by using the rapid development approach. It also aimed to address the challenges of mHealth app adoption and sustained use.

methodsThe Rapid Application Development approach was adopted. Stakeholders including decision makers, physicians, nurses, health care administrators, and research engineers were engaged. The process began with requirements gathering to define and finalize the project scope, followed by an iterative process of developing a working prototype, conducting User Acceptance Tests, and improving the prototype before implementation. Co-designing principles were applied to ensure equal collaborative efforts and collective agreement among stakeholders.

resultsDrCovid+ was developed on Telegram Messenger and hosted on a cloud server. It features a secure patient enrollment and data interface, a multilingual communication channel, and both automatic and personalized push messaging. A back-end dashboard was also developed to collect patients' vital signs for remote monitoring and continuity of care. To date, 400 patients have been enrolled into the system, amounting to 2822 hospital bed-days saved.

conclusionsThe rapid development and implementation of DrCovid+ allowed for timely clinical care management for patients with COVID-19. It facilitated early patient hospital discharge and continuity of care while addressing issues relating to data security and labor-, time-, and cost-effectiveness. The use case for DrCovid+ may be extended to other medical conditions to advance patient care and empowerment within the community, thereby meeting existing and rising population health challenges.

Indexed as

app developmentclinical carecontinuity of careCOVID-19digital healthhospital-at-homemHealthmobile appmobile healthrapid developmentremote careTelegram servicevirtual care

Identifiers

PMID36649223
PMCPMC9907569
OpenAlexW4315563745

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.